In radionuclide imaging, the most useful radiopharmaceutical agent for skeletal imaging is: March 2012
**Core Concept**
The question is testing the knowledge of radionuclide imaging, specifically the use of radiopharmaceutical agents for skeletal imaging. The underlying principle is the ability of certain agents to selectively accumulate in bone tissue, allowing for visualization of skeletal structures.
**Why the Correct Answer is Right**
Technetium-99m-methyl diphosphonate (Tc-99m MDP) is the most commonly used radiopharmaceutical agent for skeletal imaging due to its high affinity for hydroxyapatite, a major component of bone tissue. This results in rapid and intense accumulation of the radiotracer in areas of increased bone turnover, such as fractures, tumors, and osteomyelitis. The mechanism of uptake is thought to involve the formation of a stable complex between Tc-99m MDP and calcium ions in the hydroxyapatite crystal lattice.
**Why Each Wrong Option is Incorrect**
* **Option A:** Technetium-99m-pentetate (Tc-99m DTPA) is primarily used for renal function studies and does not accumulate in bone tissue.
* **Option B:** Gallium-67 citrate is used for detecting infections and certain tumors, but it is not specific for skeletal imaging.
* **Option C:** Indium-111-labeled leukocytes are used for detecting infections and abscesses, but they are not typically used for skeletal imaging.
**Clinical Pearl / High-Yield Fact**
Tc-99m MDP is a highly sensitive and specific agent for detecting skeletal metastases, particularly in the evaluation of patients with known or suspected cancer.
**Correct Answer: C. Gallium-67 citrate.**